Investors including Bain Capital backed the company's thesis that next-generation multi-receptor agonists and oral small molecules could capture meaningful share from first-generation agents
Available from: Wilson A
In summary, the results of this analysis support that some individuals may experience changes to the menstrual cycle when taking GLP-1 medications for weight loss, specifically with periods becoming more predictable and frequent
Real-World Use and Effectiveness of Tirzepatide Among People Without Evidence of Type 2 Diabetes in the United States
Fink-Jensen A, Wrtwein G, Klausen MK, Holst JJ, Hartmann B, Thomsen M, et al
Its also possible that by improving menopause symptoms hot flashes, night sweats, sleep issues, urinary issues youre in a better place to lose weight